Scientists established a human isogenic cell line panel based on Down syndrome-specific iPSCs, the XIST-mediated transcriptional silencing system in trisomic chromosome 21, and genome/chromosome-editing technologies to eliminate phenotypic fluctuations caused by genetic variation.
[Communications Biology]
Sorry, but the selected Zotpress account can't be found.
